Anti-CD22-AcBut-CalichDMH ADC

CAT#: ADC-006LZY

This ADC product is composed of an anti-CD22 antibody conjugated via AcBut linker to CalichDMH (inotuzumab-AcBut-CalichDMH). It is in PhaseIII clinical trials and has demonstrated a response in Non-Hodgkin's Lymphoma (NHL), diffuse large B-cell lymphoma(DLBCL), chronic lymphocytic leukaemia(CLL) treatment by a MOA (Mechanism of Action) of binding to DNA minor groove and causing sequence-specific double-strand DNA cleavage.

Gene Expression
Figure 1 Lymph node Figure 2 Spleen Figure 3 RNA cell line category: Cell line enhanced (Daudi, REH, U-698, WM-115)

Specifications

  • Antibody Overview
  • Inotuzumab (Humanized Anti-CD22 mAb)
  • Linker
  • AcBut (4-(4-acetylphenoxy)butanoic acid)
  • Linker Class/Description
  • Class: Chemically cleavable Linker-Acid-labile linker
    Description: Acid-labile linkers, belonging to chemically cleavable linkers, are designed based on a pH-dependent release mechanism and remain intact during systemic circulation in the blood's neutral pH environment (pH 7.3–7.5) but to undergo hydrolysis and release drug once the ADC is internalized into mildly acidic endosomal (pH 5.0–6.5) and lysosomal (pH 4.5–5.0) compartments of the cell.
  • Drug
  • CalichDMH
  • Drug Class/Description
  • Class: Calicheamicin
    Description: Calicheamicin, produced by prokaryotic microorganisms, are a group of DNA cleaving agents with similar structure that binds in the minor grove of DNA in a relatively sequence-specific manner.

Target

  • Introduction
  • CD22, or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins. It is found on the surface of mature B cells and to a lesser extent on some immature B cells. Generally speaking, CD22 is a regulatory molecule that prevents the overactivation of the immune system and the development of autoimmune diseases.
    CD22 is a sugar binding transmembrane protein, which specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. The presence of Ig domains makes CD22 a member of the immunoglobulin superfamily. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signaling. It is also involved in the B cell trafficking to Peyer's patches in mice.
  • Alternative Names
  • CD22; CD22 molecule; SIGLEC2; SIGLEC-2; B-cell receptor CD22; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; B-lymphocyte cell adhesion molecule; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2;
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for ADC-006LZY. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "CD22"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
AGTO-L048E anti-CD22 immunotoxin RFB4 (scFv)-PE Cytotoxicity assay, Functional assay
AGTO-L048D anti-CD22 immunotoxin RFB4 (scFv)-DT Cytotoxicity assay, Functional assay
AGTO-L048G anti-CD22 immunotoxin RFB4 (scFv)-Gel Cytotoxicity assay, Functional assay
AGTO-L048R anti-CD22 immunotoxin RFB4 (scFv)-RTA Cytotoxicity assay, Functional assay
AGTO-L048S anti-CD22 immunotoxin RFB4 (scFv)-Sap Cytotoxicity assay, Functional assay
CAT Product Name Application Type
Gly-001LC Recombinant Anti-Human CD22 Antibody (Fab glycosylation) ELISA, FC Mouse antibody
CAT Product Name Application Type
Gly-111LC Recombinant Anti-Human CD22 Antibody (Fc glycosylation) ELISA Chimeric antibody (mouse/human)
CAT Product Name Application Type
NEUT-315CQ Rat Anti-CD22 Recombinant Antibody (clone 2D6) Block Rat IgG1, κ
CAT Product Name Application Type
MOR-0545 Hi-Affi™ Rabbit Anti-CD22 Recombinant Antibody (clone DS545AB) IP, WB Rabbit IgG
CAT Product Name Application Type
AFC-TAB-176 Afuco™ Anti-CD22 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-176) IF, IP, Neut, FuncS, ELISA, FC ADCC enhanced antibody
AFC-TAB-198 Afuco™ Anti-CD22 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-198) ELISA, FC, IP, FuncS, IF, Neut ADCC enhanced antibody
CAT Product Name Application Type
VS-0424-XY50 AbPlus™ Anti-CD22 Magnetic Beads (DM13) IP, Protein Purification
VS-0724-YC918 AbPlus™ Anti-Cd22 Magnetic Beads (VS-0724-YC918) IP, Protein Purification
CAT Product Name Application Type
VS-0225-XY24 CytoStream™ Mouse Anti-CD22 Recombinant Antibody (VS-0225-XY24) FC Mouse IgG1, kappa
CAT Product Name Application Type
VS-0425-FY82 Human Anti-CD22 (clone Inotuzumab) scFv-Fc Chimera ELISA Human IgG4, scFv-Fc
CAT Product Name Application Type
VS-0425-YC225 Recombinant Anti-CD22 Vesicular Antibody, EV Displayed (VS-0425-YC225) ELISA, FC, Neut, Cell-uptake
CAT Product Name Application Type
VS-0525-YC201 Recombinant Anti-CD22 (Epitope A x Epitope B) Biparatopic Antibody, Tandem scFv ELISA, FC, ICC, IF, IP, Neut Tandem scFv
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare